Tosi P; Zamagni E; Tacchetti P; Ceccolini M; Perrone G; Brioli A; Pallotti MC; Pantani L; Petrucci A; Baccarani M; Cavo M., Thalidomide-dexamethasone as induction therapy before autologous stem cell transplantation in patients with newly diagnosed multiple myeloma and renal insufficiency., «BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION», 2010, 16, pp. 1115 - 1121 [articolo]
Cini M; Zamagni E; Valdré L; Palareti G; Patriarca F; Tacchetti P; Legnani C; Catalano L; Masini L; Tosi P; Gozzetti A; Cavo M, Thalidomide-dexamethasone as up-front therapy for patients with newly diagnosed multiple myeloma: thrombophilic alterations, thrombotic complications, and thromboprophylaxis with low-dose warfarin., «EUROPEAN JOURNAL OF HAEMATOLOGY», 2010, 84, pp. 484 - 492 [articolo]
Perrone G; Hideshima T; Ikeda H; Okawa Y; Calabrese E; Gorgun G; Santo L; Cirstea D; Raje N; Chauhan D; Baccarani M; Cavo M; Anderson KC., Ascorbic acid inhibits antitumor activity of bortezomib in vivo, «LEUKEMIA», 2009, 23(9), pp. 1679 - 1686 [articolo]
Patriarca F; Petrucci MT; Bringhen S; Baldini L; Caravita T; Corradini P;
Corso A; Di Raimondo F; Falcone A; Ferrara F; Morabito F; Musto P; Offidani M; Petrini M; Rizzi R; Semenzato G; Tosi P; Vacca A; Cavo M; Boccadoro M; Palumbo A., Considerations in the treatment of multiple myeloma: a consensus statement from Italian experts., «EUROPEAN JOURNAL OF HAEMATOLOGY», 2009, 82, pp. 93 - 105 [articolo]
Musto P; D'Auria F; Pietrantuono G; Baldini L; Bringhen S; Caravita T; Di Raimondo F; Morabito F; Offidani M; Petrucci MT; Tosi P; Gay F; Cavo M; Boccadoro M; Palumbo A., First-line treatment of multiple myeloma in elderly patients: the GIMEMA (Gruppo Italiano Malattie EMatologiche dell'Adulto) multiple myeloma working party perspective., «CURRENT DRUG TARGETS», 2009, 10, pp. 906 - 922 [articolo]
Dispenzieri A, Kyle R, Merlini G, Miguel JS, Ludwig H, Hajek R, Palumbo A, Jagannath S, Blade J, Lonial S, Dimopoulos M, Comenzo R, Einsele H, Barlogie B, Anderson K, Gertz M, Harousseau JL, Attal M, Tosi P, Sonneveld P, Boccadoro M, Morgan G, Richardson P, Sezer O, Mateos MV, Cavo M, Joshua D, Turesson I, Chen W, Shimizu K, Powles R, Rajkumar SV, Durie BG; International Myeloma Working Group., International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders., «LEUKEMIA», 2009, 23, pp. 215 - 224 [articolo]
Palumbo A; Sezer O; Kyle R; Miguel JS; Orlowski RZ; Moreau P; Niesvizky R; Morgan G; Comenzo R; Sonneveld P; Kumar S; Hajek R; Giralt S; Bringhen S; Anderson KC; Richardson PG; Cavo M; Davies F; Bladé J; Einsele H; Dimopoulos MA; Spencer A; Dispenzieri A; Reiman T; Shimizu K; Lee JH; Attal M; Boccadoro M; Mateos M; Chen W; Ludwig H; Joshua D; Chim J; Hungria V; Turesson I; Durie BG; Lonial S; IMWG, International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation., «LEUKEMIA», 2009, 23(10), pp. 1716 - 1730 [articolo]
Giralt S; Stadtmauer EA; Harousseau JL; Palumbo A; Bensinger W; Comenzo RL; Kumar S; Munshi NC; Dispenzieri A; Kyle R; Merlini G; San Miguel J; Ludwig H; Hajek R; Jagannath S; Blade J; Lonial S; Dimopoulos MA; Einsele H; Barlogie B; Anderson KC; Gertz M; Attal M; Tosi P; Sonneveld P; Boccadoro M; Morgan G; Sezer O; Mateos MV; Cavo M; Joshua D; Turesson I; Chen W; Shimizu K; Powles R;
Richardson PG; Niesvizky R; Rajkumar SV; Durie BG; IMWG., International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100)., «LEUKEMIA», 2009, 23(10), pp. 1904 - 1912 [articolo]
Kumar S; Giralt S; Stadtmauer EA; Harousseau JL; Palumbo A; Bensinger W; Comenzo RL; Lentzsch S; Munshi N; Niesvizky R; San Miguel J; Ludwig H; Bergsagel L; Blade J; Lonial S; Anderson KC; Tosi P; Sonneveld P; Sezer O; Vesole D; Cavo M; Einsele H; Richardson PG; Durie BG; Rajkumar SV; International Myeloma Working Group., Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimens., «BLOOD», 2009, 114(9), pp. 1729 - 1736 [articolo]
Cavo M; Di Raimondo F; Zamagni E; Patriarca F; Tacchetti P; Casulli AF; Volpe S; Perrone G; Ledda A; Ceccolini M; Califano C; Bigazzi C; Offidani M; Stefani P; Ballerini F; Fiacchini M; de Vivo A; Brioli A; Tosi P; Baccarani M., Short-term thalidomide incorporated into double autologous stem-cell transplantation improves outcomes in comparison with double autotransplantation for multiple myeloma., «JOURNAL OF CLINICAL ONCOLOGY», 2009, 27(30), pp. 5001 - 5007 [articolo]
Rapezzi C; Merlini G; Quarta CC; Riva L; Longhi S; Leone O; Salvi F; Ciliberti P; Pastorelli F; Biagini E; Coccolo F; Cooke RM; Bacchi-Reggiani L; Sangiorgi D; Ferlini A; Cavo M; Zamagni E; Fonte ML; Palladini G; Salinaro F; Musca F; Obici L; Branzi A; Perlini S., Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types., «CIRCULATION», 2009, 13, pp. 1203 - 1212 [articolo]
Cavo M; Pantani L; Tacchetti P; Pallotti MC; Brioli A; Petrucci A; Zamagni E; Tosi P., Thalidomide maintenance in multiple myeloma: certainties and
controversies., «JOURNAL OF CLINICAL ONCOLOGY», 2009, 27(32), pp. 186 - 187 [replica/breve intervento]
Cavo M.; Zamagni E.; Tacchetti P.; Brioli A.; Pallotti C.; Pantani L.; Ceccolini M.; Petrucci A.; Testoni N.; Terragna C.; Marzocchi G.; Durante S.; Tosi P.; Baccarani M., The road to cure in multiple myeloma: Incorporation of novel agents into autologous stem cell transplantation, «HEMATOLOGY MEETING REPORTS», 2009, 3, pp. 24 - 25 [articolo]
Terpos E; Sezer O; Croucher PI; García-Sanz R; Boccadoro M; San Miguel J; Ashcroft J; Bladé J; Cavo M; Delforge M; Dimopoulos MA; Facon T; Macro M; Waage A; Sonneveld P; European Myeloma Network., The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network., «ANNALS OF ONCOLOGY», 2009, 20(8), pp. 1303 - 1317 [articolo]
San Miguel JF, Schlag R, Khuageva NK, Dimopoulos MA, Shpilberg O, Kropff M,Spicka I, Petrucci MT, Palumbo A, Samoilova OS, Dmoszynska A, Abdulkadyrov KM,Schots R, Jiang B, Mateos MV, Anderson KC, Esseltine DL, Liu K, Cakana A, van de Velde H, Richardson PG; VISTA Trial Investigators [..; Cavo M; ..], Bortezomib plus melphalan and prednisone for initial treatment of multiple
myeloma., «THE NEW ENGLAND JOURNAL OF MEDICINE», 2008, 359, pp. 906 - 917 [articolo]
